Elevance Health Inc
NYSE:ELV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elevance Health Inc
NYSE:ELV
|
US |
|
INmune Bio Inc
NASDAQ:INMB
|
US |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
MatsukiyoCocokara & Co
TSE:3088
|
JP |
|
Montrose Environmental Group Inc
NYSE:MEG
|
US |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XHAM:MOH
|
FR |
|
R
|
Rojana Industrial Park PCL
SET:ROJNA
|
TH |
|
EDA Group Holdings Ltd
HKEX:2505
|
CN |
|
Gimv NV
XBRU:GIMB
|
BE |
|
Tempur Sealy International Inc
NYSE:TPX
|
US |
|
CONSOL Energy Inc
NYSE:CEIX
|
US |
|
T
|
Truist Financial Corp
SWB:BBK
|
US |
|
M
|
MacroAsia Corp
XPHS:MAC
|
PH |
|
Unity Software Inc
NYSE:U
|
US |
|
SMCP SA
PAR:SMCP
|
FR |
|
Mckesson Corp
NYSE:MCK
|
US |
|
Taylor Devices Inc
NASDAQ:TAYD
|
US |
Wall St Price Targets
ELV Price Targets Summary
Elevance Health Inc
According to Wall Street analysts, the average 1-year price target for ELV is 399.68 USD with a low forecast of 334.31 USD and a high forecast of 516.02 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ELV's stock price target?
Price Target
399.68
USD
According to Wall Street analysts, the average 1-year price target for ELV is 399.68 USD with a low forecast of 334.31 USD and a high forecast of 516.02 USD.
What is the Revenue forecast for Elevance Health Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 3%.
What is the Net Income forecast for Elevance Health Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 8 years is 11%.
